Nature Medicine, Published online: 19 May 2026; doi:10.1038/d41591-026-00026-2
The portable, low-resource MiniDock MTB test, evaluated across multiple countries, shows promise for detecting pulmonary tuberculosis using sputum and tongue swabs.
Nature Medicine, Published online: 19 May 2026; doi:10.1038/d41591-026-00026-2
The portable, low-resource MiniDock MTB test, evaluated across multiple countries, shows promise for detecting pulmonary tuberculosis using sputum and tongue swabs.
SAN FRANCISCO — Former Stanford President Marc Tessier-Lavigne responded publicly for the first time Tuesday to allegations in a new book that he was forced to resign from the university not only because of flaws in his oversight of scientists but over how he handled the controversy.
At the STAT Breakthrough Summit West, STAT reporter Matthew Herper read aloud three paragraphs from Theo Baker’s book, “How to Rule the World.’’ Tessier-Lavigne sat with hands clasped in his lap as he listened to Baker’s description of the board meeting that led to his ouster.
According to Baker, the board concluded “that Tessier-Lavigne’s admit-nothing, deny-everything approach ‘did not reflect well on him and, by extension, the institution.’” The Stanford investigation, according to unnamed sources in the book, omitted yet another incident that contributed to the university turning on Tessier-Lavigne — a younger, female colleague challenging the conclusions of his work, and him dismissing her. By the end of the meeting, “there was no pro-MTL camp” and the board voted unanimously to replace him, Baker wrote.
WASHINGTON — For years, the United States has poured hundreds of millions of dollars into programs to prevent and control infectious diseases in the Democratic Republic of the Congo.
But in the months leading up to a fast-moving Ebola outbreak, the Trump administration slashed aid to the country, leading to a cascade of consequences that probably hampered the detection of the outbreak and the response to it, six people involved in or familiar with the efforts in the region said.
Background: The COVID-19 pandemic was marked by rapidly evolving and inconsistent public health messaging, contributing to confusion regarding recommended preventive behaviors. Knowledge, attitudes, and practices (KAP) and perceived risk frameworks offer a structured approach to examine how education, personal beliefs, and contextual factors influence health behaviors during public health emergencies. Vulnerable populations, such as patients with multiple sclerosis (MS), experience heightened risk perception compared with the general population, which may further shape behavioral responses. Objective: This study aimed to examine COVID-19–related KAP and perceived risk among patients with MS, health care providers, and laypeople during the first 6 months of the pandemic. The aim of mixed methods was to explore quantitative factors associated with KAP and perceived risk and to qualitatively describe participants’ perceptions and emotional responses to the pandemic. Methods: A descriptive, cross-sectional, partially mixed methods explanatory sequential design was used. Participants were recruited using convenience sampling and completed an online demographic questionnaire and a COVID-19 KAP instrument that included perceived risk items. Quantitative data were analyzed using descriptive statistics and inferential analyses to examine group differences and associations between perceived risk and preventive behaviors. Chi-square testing was applied to compare perceived risk across groups, and correlational analyses were used to examine the relationships between perceived risk and behavioral practices. Qualitative comments provided by participants were analyzed using thematic analysis to further contextualize quantitative findings and to explore perceived risk experiences. Results: A total of 148 participants were included, comprising 43 (29%) individuals with MS, 50 (33.8%) health care providers, and 55 (37.2%) laypeople. Overall, 90% (n=133) of participants demonstrated basic knowledge of COVID-19 transmission and prevention. Attitudes toward public health guidance and self-reported preventive behaviors varied across groups. Lay participants most frequently reported a moderate perceived risk of COVID-19 infection, whereas participants with MS and health care providers more commonly reported high perceived risk (²=12.65, =.049). Neither immunosuppressive treatment status nor vaccine hesitancy significantly predicted perceived risk. However, higher perceived risk was significantly associated with greater avoidance of crowded and public places. Qualitative analysis yielded 5 interrelated themes describing participants’ perceived risk experiences: uncertainty related to evolving scientific information; anxiety regarding personal and family safety; fear of infection and long-term consequences; vulnerability, particularly among individuals with chronic illness and frontline exposure; and accountability toward protecting others through adherence to preventive measures. These themes provided contextual insight into the emotional and cognitive processes underlying reported attitudes and behaviors. Conclusions: Knowledge of COVID-19 is associated with favorable attitudes and engagement in preventive practices across populations. Differences in perceived risk highlight the importance of tailoring risk communication and educational strategies to specific populations. KAP-focused educational interventions that explicitly address uncertainty, emotional responses, and behavioral translation may strengthen preparedness and promote sustained protective behaviors during future public health emergencies. Trial Registration: ClinicalTrials.gov NCT07021716; https://clinicaltrials.gov/ct2/show/NCT07021716
<img src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/5eef2f4db696516c49b8f739973d5ff1" />
Virginia Gov. Abigail Spanberger has vetoed closely watched legislation to create an advisory panel to lower prescription drug costs, a setback to attempts by lawmakers across the United States to address the rising cost of medicines.
Unlike affordability boards in other states, the Virginia panel would have used Medicare as a benchmark. Rather than start from scratch to identify drugs considered expensive, each year the panel would have targeted the same drugs chosen by Medicare for price negotiations. The board would have also set upper payment limits to create a ceiling on what would be paid.
By doing so, Virginia would have leapfrogged plans by other states that are at varying stages of establishing affordability boards. Of the other nine states that have boards, none is eyeing all of the same drugs chosen annually by Medicare and only four have the authority to set upper payment limits.
When health insurers contract with providers, they agree on prices for all kinds of procedures. For a lumbar laminectomy, a common spine surgery for ailments like herniated discs or arthritis, the median price is $1,400.
Out-of-network providers, those that don’t contract with health insurers, are getting 24 times that amount for the same surgery at the median — nearly $34,000 — through the No Surprises Act’s arbitration process. Some are even getting north of $100,000.
The lumbar laminectomy is just one example of the extraordinarily high awards being doled out under the flawed system created by the 2020 law. The law has successfully protected patients from unexpected bills, but it’s also been a major boon for providers. They’re not only securing massive sums when they win, but they’re also prevailing in over 80% of disputes.
In the first, tenuous weeks of her life, Jorie Kraus and her parents faced her possible death repeatedly. Muscles throughout her tiny body simply didn’t work properly. Her heart. Her legs. Her larynx. Even the involuntary action of breathing was labored, and constantly faltering.
In those panicked days, through a haze of terrible news and incomprehensible instructions, something incredible happened: A long-shot attempt to discover the root cause of her problems identified a widely available, yet previously unknown, treatment.
Listen to the session or watch below
Elon Musk lost his suit against OpenAI, in which he alleged CEO Sam Altman and President Greg Brockman had deceived him over the company’s non-profit status.
Watch as AI reporter and attorney Michelle Kim, who covered the trial for MIT Technology Review, joins in conversation with editor in chief Mat Honan to go behind the scenes of the trial and the implications for the AI race.
Speakers: Mat Honan, Editor in Chief, and Michelle Kim, AI Reporter
Recorded on May 19, 2026
Related Stories: